Age and life expectancy clocks based on machine learning analysis of mouse frailty
- PMID: 32934233
- PMCID: PMC7492249
- DOI: 10.1038/s41467-020-18446-0
Age and life expectancy clocks based on machine learning analysis of mouse frailty
Erratum in
-
Publisher Correction: Age and life expectancy clocks based on machine learning analysis of mouse frailty.Nat Commun. 2020 Oct 8;11(1):5143. doi: 10.1038/s41467-020-19046-8. Nat Commun. 2020. PMID: 33033247 Free PMC article.
Abstract
The identification of genes and interventions that slow or reverse aging is hampered by the lack of non-invasive metrics that can predict the life expectancy of pre-clinical models. Frailty Indices (FIs) in mice are composite measures of health that are cost-effective and non-invasive, but whether they can accurately predict health and lifespan is not known. Here, mouse FIs are scored longitudinally until death and machine learning is employed to develop two clocks. A random forest regression is trained on FI components for chronological age to generate the FRIGHT (Frailty Inferred Geriatric Health Timeline) clock, a strong predictor of chronological age. A second model is trained on remaining lifespan to generate the AFRAID (Analysis of Frailty and Death) clock, which accurately predicts life expectancy and the efficacy of a lifespan-extending intervention up to a year in advance. Adoption of these clocks should accelerate the identification of longevity genes and aging interventions.
Conflict of interest statement
D.A.S. is a founder, equity owner, advisor to, director of, consultant to, investor in and/or inventor on patents licensed to Vium, Jupiter Orphan Therapeutics, Cohbar, Galilei Biosciences, GlaxoSmithKline, OvaScience, EMD Millipore, Wellomics, Inside Tracker, Caudalie, Bayer Crop Science, Longwood Fund, Zymo Research, Immetas, and EdenRoc Sciences (and affiliates Arc-Bio, Dovetail Genomics, Claret Bioscience, Revere Biosensors, UpRNA and MetroBiotech, Liberty Biosecurity); Life Biosciences (and affiliates Selphagy, Senolytic Therapeutics, Spotlight Biosciences, Animal Biosciences, Iduna, Continuum Biosciences, Jumpstart Fertility (an NAD booster company), and Lua Communications); Iduna is a cellular reprogramming company, partially owned by Life Biosciences. D.S.V. sits on the board of directors of both companies. D.A.S. is an inventor on a patent application filed by Mayo Clinic and Harvard Medical School that has been licensed to Elysium Health; his personal share is directed to the Sinclair lab. For more information see
Figures
References
-
- Butler RN, et al. Aging: the reality: biomarkers of aging: from primitive organisms to humans. J. Gerontol. A Biol. Sci. Med. Sci. 2004;59:B560–B567. - PubMed
-
- Rantanen T, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J. Gerontol. A Biol. Sci. Med. Sci. 2000;55:168–173. - PubMed
-
- Bittner V, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707. - PubMed
-
- Martínez de Toda I, Vida C, Sanz San Miguel L, De la Fuente M. When will my mouse die? Life span prediction based on immune function, redox and behavioural parameters in female mice at the adult age. Mech. Ageing Dev. 2019;182:111125. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
